Rxsight Ownership

RXST Stock

USD 50.38 0.81 1.63%

Rxsight owns a total of 39.68 Million outstanding shares. The majority of Rxsight outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Rxsight to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Rxsight. Please pay attention to any change in the institutional holdings of Rxsight as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Some institutional investors establish a significant position in stocks such as Rxsight in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Rxsight, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Dividends Paid is likely to drop to about 514.4 K in 2024. Dividend Paid And Capex Coverage Ratio is likely to drop to -9.56 in 2024. Common Stock Shares Outstanding is likely to drop to about 31.8 M in 2024. Net Loss is likely to gain to about (57.1 M) in 2024.

Market Cap Enterprise Value

Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rxsight. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Rxsight Stock Ownership Analysis

About 88.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Rxsight recorded a loss per share of 0.99. The entity had not issued any dividends in recent years. RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses used in cataract surgery in the United States and internationally. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California. Rxsight operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 221 people. To find out more about Rxsight contact Ronald MD at 949 521 7830 or learn more at https://www.rxsight.com.

Besides selling stocks to institutional investors, Rxsight also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Rxsight's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Rxsight's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Rxsight Quarterly Liabilities And Stockholders Equity

305.5 Million

Rxsight Insider Trades History

About 5.0% of Rxsight are currently held by insiders. Unlike Rxsight's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Rxsight's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Rxsight's insider trades

Yuan Drop

Covid

Rxsight Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Rxsight is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Rxsight backward and forwards among themselves. Rxsight's institutional investor refers to the entity that pools money to purchase Rxsight's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Bank Of America Corp	2024-06-30	755.3 K
Driehaus Capital Management Llc	2024-06-30	706.2 K
Geode Capital Management, Llc	2024-06-30	694.3 K
Gilder Gagnon Howe & Co Llc	2024-06-30	605.5 K
Nuveen Asset Management, Llc	2024-06-30	559.1 K
Next Century Growth Investors Llc	2024-06-30	528.3 K
Atika Capital Management Llc	2024-06-30	402.6 K
Baillie Gifford & Co Limited.	2024-06-30	358.2 K
No Street Gp Lp	2024-06-30	350 K
Ra Capital Management, Llc	2024-06-30	3.7 M
Blackrock Inc	2024-06-30	2.4 M

Note, although Rxsight's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Rxsight Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Rxsight insiders, such as employees or executives, is commonly permitted as long as it does not rely on Rxsight's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Rxsight insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Ilya Goldshleger few days ago Disposition of 3100 shares by Ilya Goldshleger of Rxsight at 49.6778 subject to Rule 16b-3
		Ilya Goldshleger over a week ago Disposition of 3100 shares by Ilya Goldshleger of Rxsight at 49.7799 subject to Rule 16b-3
		Ilya Goldshleger over a week ago Disposition of 3100 shares by Ilya Goldshleger of Rxsight at 50.0865 subject to Rule 16b-3
		Ilya Goldshleger over two weeks ago Disposition of 3100 shares by Ilya Goldshleger of Rxsight at 50.1915 subject to Rule 16b-3
		Ilya Goldshleger over two weeks ago Disposition of 3105 shares by Ilya Goldshleger of Rxsight at 48.8231 subject to Rule 16b-3
		Ilya Goldshleger over two weeks ago Disposition of 206 shares by Ilya Goldshleger of Rxsight at 48.65 subject to Rule 16b-3
		Ilya Goldshleger over three weeks ago Disposition of 3105 shares by Ilya Goldshleger of Rxsight at 49.2926 subject to Rule 16b-3
		Ilya Goldshleger over a month ago Disposition of 3100 shares by Ilya Goldshleger of Rxsight at 56.111 subject to Rule 16b-3
		Kurtz Ronald M Md over two months ago Disposition of 2300 shares by Kurtz Ronald M Md of Rxsight at 4.3386 subject to Rule 16b-3
		Eric Weinberg over two months ago Disposition of 10000 shares by Eric Weinberg of Rxsight at 48.0006 subject to Rule 16b-3
		Eric Weinberg over two months ago Acquisition by Eric Weinberg of 92200 shares of Rxsight at 56.07 subject to Rule 16b-3
		Kurtz Ronald M Md over three months ago Disposition of 13500 shares by Kurtz Ronald M Md of Rxsight at 15.0818 subject to Rule 16b-3

Rxsight Outstanding Bonds

Rxsight issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Rxsight uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Rxsight bonds can be classified according to their maturity, which is the date when Rxsight has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Boeing Co 2196 Corp Bond US097023DG73	View
	MPLX LP 4125 Corp Bond US55336VAK61	View
	MPLX LP 52 Corp Bond US55336VAL45	View
	AerCap Global Aviation Corp Bond US00773HAA59	View

View All Rxsight Corporate Bonds

Rxsight Corporate Filings

13A	22nd of October 2024 An amended filing to the original Schedule 13G	View Verify
F4	18th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities	View Verify
8K	5th of August 2024 Report filed with the SEC to announce major events that shareholders should know about	View Verify
	16th of May 2024 Other Reports	View Verify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC